Keros Therapeutics, Inc.
KROSNASDAQNASDAQ Global Market·USD·Closed
$17.91
−$0.08 (0.44%)
$17.91
−$0.08 (0.44%)
Not investment advice.Learn more
KROS presents a mixed picture — bulls and bears both have arguments.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Mid-range
Volume
Market Cap
Small-cap company
P/E Ratio
Cheap relative to earnings
Div Yield
No dividend